Minapharm Pharmaceuticals S.A.E., ThromboGenics deal

Minapharm's Rhein-Minapharm-Biogenetics S.A.E. subsidiary received exclusive rights to develop and commercialize THR's THR-174 in Middle Eastern and North African countries. THR will receive an undisc...